The Pacific Journal of Cardiovascular Innovations (PJCI), pISSN: 3068-3238, eISSN: 3068-0379 published by American Science Press LLC, USA, is a prestigious, open-access, double-blind, peer-reviewed international journal at the forefront of cardiovascular research and innovation. Dedicated to the dissemination of pioneering scientific knowledge, PJCI provides a premier platform for the publication of cutting-edge research, clinical advancements, and technological innovations in the realm of cardiovascular medicine. With a comprehensive focus on cardiovascular diseases, PJCI publishes high-caliber, original research articles, systematic reviews, clinical trials, case reports, and technical notes. The journal explores a wide array of topics, including but not limited to, heart failure, coronary artery disease, vascular pathophysiology, arrhythmias, cardiovascular surgery, and interventional cardiology. Additionally, it emphasizes emerging fields such as genetic cardiovascular disorders, personalized medicine, cardiovascular biomarkers, and the integration of artificial intelligence and machine learning in diagnostics and treatment. PJCI is committed to upholding the highest academic standards, with a rigorous peer-review process ensuring that all published content is scientifically robust, clinically relevant, and impactful. By fostering global collaboration among leading clinicians, researchers, and healthcare innovators, PJCI plays a pivotal role in shaping the future of cardiovascular care. As an open-access journal, it ensures that transformative research reaches a global audience, contributing to enhanced patient outcomes and the evolution of cardiovascular health worldwide.